Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase BsSDR10. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118755682A reveals BsSDR10 mutants for tetrabenazine reduction. Discover cost-effective, high-selectivity biocatalytic solutions for chiral drug manufacturing.
Patent CN117402920A details a novel ketoreductase mutant for asymmetric reduction. This report analyzes cost reduction in chiral drug manufacturing and supply chain reliability for global buyers.